Business Daily Media

Men's Weekly

.

Cardinal Health acquires smart prescription platform ScalaMed


Cardinal Health (NYSE:CAH) announced the acquisition of ScalaMed, a HIPAA-compliant, smart platform that transfers prescriptions directly to patients via a secure mobile app. The acquisition transfers ScalaMed’s technology and assets to Outcomes™, a Cardinal Health company.

ScalaMed pivots prescription management from provider to patient, allowing patients to send prescriptions written by their provider directly to any pharmacy for the first fill. The platform offers patients greater flexibility, easier access, and price comparison to select the pharmacy of their choice.

For providers, the platform eliminates the administrative work of transferring prescriptions, saving the average clinician 40 hours per year, and helps improve health outcomes with improved adherence, and increased patient satisfaction. Scalamed’s technology will be offered through the Cardinal Health nationwide pharmacy network, creating unprecedented opportunities for digital connectivity to millions of patients.

“As healthcare continues to evolve toward patient preferences, the acquisition of ScalaMed allows us to center our connected ecosystem around the patient from the outset of their treatment journey - from the doctor’s office to the pharmacy to home,” said Brent Stutz, SVP/GM of Outcomes™, a Cardinal Health Company. “Using ScalaMed’s technology, we can better support patients at every step along their treatment journey through unified communication and more informed insights that will help remove access and adherence barriers.”

Built by physicians and pharmacists with first-hand knowledge of how prescriptions are often mismanaged in the current healthcare system, ScalaMed worked to develop a digital solution that empowered patients and personalized their care, taking into account the real-world challenges of daily life that often lead to medication nonadherence.

“The process of digitizing prescriptions removes the patient from the equation and overlooks the complexity of the real-life adherence challenges patients face – forgetting medication on vacation, not having a pharmacy with convenient hours nearby, the variables are endless,” said Dr. Tal Rapke, MD CEO and Founder of ScalaMed. “We’re excited to partner with a leader in pharmacy like Cardinal Health, so that together, we can offer a solution that is both smart and patient-centric. With the scale and innovation Cardinal Health offers, we can revolutionize how prescriptions are filled and help solve the massive, costly challenge of medication nonadherence.”

Brisbane’s brightest recognised: Daniel Mikus and James Rolph win Specialist Services Award at the 2025 Brisbane Young Entrepreneur Awards - again

Young Brisbane entrepreneurs Daniel Mikus and James Rolph, cofounders of MR Group, have been officially crowned winners of the Specialist Services...

Members greenlight merger of Regional Australia Bank and Summerland Bank

Regional Australia Bank and Summerland Bank will proceed with a merger after members approved the move at their Annual General Meetings this week...

DesignStreet marks 27 years with a bold rebrand

In a fast-moving industry defined by continuous disruption, one independent creative agency is proving that longevity and innovation can go hand i...

Deputy partners with SuperAPI to streamline employee onboarding and help get shift-based industries ready for PayDay Super

Deputy, the global people platform for shift-based work, has announced a new partnership with SuperAPI, marking a major enhancement to its HR pro...

KuCoin invests in Australian sponsorships of the ACC, plus a major campaign with golf icon Adam Scott

KuCoin, a leading global crypto platform built on trust, announced the appointment of James Pinch as the Australian Managing Director, the establish...

Australian companies pitching to the world’s wealthiest investors

#CapTech 2025 to bring world investors to Australia’s doorstep  One of Australia’s leading business and capital events is bringing together inves...